Corneal Thinning During Topical Bevacizumab Therapy

Yonsei University

Status: Withdrawn

Conditions: Corneal Neovascularization

Treatments: Drug: bevacizumab (Avastin)

Study type: Interventional

Funder types: Other

Identifiers

NCT00515684

4-2006-0234

Details and patient eligibility

About

The purpose of this study is to determine whether topical bevacizumab is safe or not when used in corneal neovascularization for long term period.

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• clinical diagnosis of corneal neovascularization
• must be able to apply eyedrop

Exclusion criteria

• have active keratitis

Trial design

Primary purpose: Basic Science

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)